✦ LIBER ✦

3–39 Prospective Evaluation of Concurrent Paclitaxel and Radiation Therapy After Adjuvant Doxorubicin and Cyclophosphamide Chemotherapy for Stage II or III Breast Cancer

✍ Scribed by Yu, T-K; Buchholz, T.A.

Book ID: 121931794
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 69 KB
Volume: 17
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(06)80525-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Noninvasive cardiac evaluation of patien

Noninvasive cardiac evaluation of patients receiving adriamycin-containing adjuvant chemotherapy (FAC) for stage II or III breast cancer

✍ M. Khalil Ali; Aman U. Buzdar; Michael S. Ewer; Renalto S. Cheng; Thomas P. Hayn 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

Cardiac function was evaluated by noninvasive methods in 55 patients with stage I1 or I11 breast cancer treated with adjuvant Adriamycin containing combination chemotherapy (FAC). None of the 44 patients who remained free of disease for a median follow-up period of 36 months, or those who were retre

tAnGo: a randomised phase III trial of g

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation

✍ Wardley, A M; Hiller, L; Howard, H C; Dunn, J A; Bowman, A; Coleman, R E; Fernan 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 241 KB

A Phase III Study of Surgical Resection

A Phase III Study of Surgical Resection and Paclitaxel/Carboplatin Chemotherapy with or Without Adjuvant Radiation Therapy for Resected Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B 9734

✍ Michael C. Perry; Leslie J. Kohman; James A. Bonner; Lin Gu; Xiaofei Wang; Evere 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 143 KB

Fifteen-year median follow-up results af

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 325 KB

O-183 A phase III study of surgical rese

O-183 A phase III study of surgical resection and chemotherapy (paclitaxel/carboplatin) (CT) with or without adjuvant radiation therapy (RT) for resected stage III non-small cell lung cancer (NSCLC): CALGB 9734

✍ Perry, Michael C.; Kohman, Leslie J.; Bonner, James A.; Zhang, Chunfeng; Herndon 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB